Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery

NCT06209294 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Immunotherapy
Cervical Cancer
Fertility-sparing Surgery

Interventions

DRUG: AK104
DRUG: Carboplatin
DRUG: Nab paclitaxel

Sponsor

Xiaohua Wu